Traveka Wealth’s GSK GSK Stock Holding History

Traveka Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,769	Closed	-$208K	–	207
2026 Q1	$208K	Buy	+3,769	New	+$204K	0.08%	171

Other funds holding GSK

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Traveka Wealth's GSK Position: Q2 2026 in Review

Traveka Wealth sold out of GSK (GSK) in Q2 2026, closing a stake of 3,769 shares — an estimated $208K sold.

Traveka Wealth first reported a position in GSK in Q1 2026 and held it in 1 quarter. The position peaked at $208K in Q1 2026. 477 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Traveka Wealth reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Traveka Wealth sold 3,769 GSK shares in Q2 2026, an estimated $208K.
Traveka Wealth first reported a position in GSK in Q1 2026 and held it in 1 quarter.
Traveka Wealth's GSK position peaked at $208K in Q1 2026.
477 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.